- What is Tagra Biotechnologies' primary focus?
- Tagra Biotechnologies specializes in microencapsulation technology for cosmetic ingredients, developing and manufacturing skin delivery systems to create successful beauty products.
- When was Tagra Biotechnologies founded?
- Tagra Biotechnologies was founded in June 1998.
- How many employees does Tagra Biotechnologies have?
- Tagra Biotechnologies has 11-50 employees.
- What are some key characteristics of Tagra Biotechnologies' ingredients?
- Tagra Biotechnologies' ingredients are globally compliant, free of preservatives, surfactants, and allergens, Halal certified, non-nano-sized, compliant with nano regulations, and not tested on animals.
- What kind of effects do Tagra Biotechnologies' microencapsulations create?
- Tagra Biotechnologies' microencapsulations create visual and sensory effects, such as color and texture transitions, and deliver stabilized actives with release on demand (RND) for improved anti-aging benefits.
- In which country is Tagra Biotechnologies headquartered?
- Tagra Biotechnologies is headquartered in Netanya, Israel.
- What is Tagra Biotechnologies' primary sector?
- Tagra Biotechnologies' primary sector is Health Tech & Life Sciences.
- Does Tagra Biotechnologies hold any patents?
- Yes, Tagra Biotechnologies holds 1 patent.
